Intrinsic Value of S&P & Nasdaq Contact Us

Sanofi SNYNF OTC

Other OTC • Healthcare • Drug Manufacturers - General • FR • USD

SharesGrow Score
68/100
5/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Sanofi (SNYNF) has a consensus analyst rating of Buy, based on 23 analysts covering the stock. Of those, 11 recommend buying, 9 recommend holding, and 3 recommend selling.

Analyst Consensus — SNYNF

Buy
Strong Buy
0
Buy
11
Hold
9
Sell
3
Strong Sell
0
23 analysts
Price Targets

No price target data available.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message